<?xml version="1.0" encoding="UTF-8" standalone="no"?><rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0">
    <channel>
        <title>Sages of Psychopharmacology Podcast</title>
        <description>The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.</description>
        <link>http://www.neiglobal.com</link>
        <copyright>Copyright © 2008 Neuroscience Education Institute. All rights reserved.</copyright>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <language>en</language>
        <lastBuildDate>Thu, 29 Oct 2009 09:54:20 -0700</lastBuildDate>
        <managingEditor>customerservice@neiglobal.com</managingEditor>
        <pubDate>Thu, 29 Oct 2009 09:53:04 -0700</pubDate>
        <generator>FeedForAll v2.0 (2.0.2.9) http://www.feedforall.com</generator>
        <itunes:subtitle>Sages of Psychopharmacology Podcast</itunes:subtitle>
        <itunes:summary>The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI?s Sages of Psychopharmacology Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.</itunes:summary>
        <itunes:author>Neuroscience Education Institute</itunes:author>
        
        
        <itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords>
        <itunes:image href="http://www.neiglobal.com/Images/global/podcast/podcast_sages_cover_art.jpg"/>
        <itunes:explicit>no</itunes:explicit>
        <itunes:block>no</itunes:block>
        <itunes:category text="Science &amp; Medicine"><itunes:category text="Medicine"/></itunes:category><itunes:owner><itunes:email>webmaster@neiglobal.com</itunes:email><itunes:name>Neuroscience Education Institute</itunes:name></itunes:owner><item>
            <title>Treating Schizophrenia With Functional Recovery As the Goal</title>
            <description>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "Treating Schizophrenia With Functional Recovery As the Goal". In this podcast (also available with video as an archived webinar), Drs. Steven Potkin and Stephen Stahl discuss strategies to optimize functional recovery in patients with schizophrenia. The podcast consists of a 45-minute interview-style discussion followed by 15-minutes of selections from the webinar question and answer periods.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=1058</link>
            <enclosure length="62000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod11-psychweb/pod11-psychweb.mp3"/>
            <guid isPermaLink="false">http://cdn.neiglobal.com/content/rss/sages/pod11-psychweb/pod11-psychweb.mp3</guid>
            <pubDate>Fri, 12 Aug 2011 12:00:00 -0700</pubDate>
            <itunes:subtitle>Treating Schizophrenia With Functional Recovery As the Goal</itunes:subtitle>
            <itunes:summary>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "Treating Schizophrenia With Functional Recovery As the Goal". In this podcast (also available with video as an archived webinar), Drs. Steven Potkin and Stephen Stahl discuss strategies to optimize functional recovery in patients with schizophrenia. The podcast consists of a 45-minute interview-style discussion followed by 15-minutes of selections from the webinar question and answer periods.</itunes:summary>
            <itunes:duration>01:06:12</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>	
		<item>
            <title>Contemporary Clinical Treatment of Schizophrenia</title>
            <description>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "Contemporary Clinical Treatment of Schizophrenia". It includes the full discussion between Drs. Andrew Cutler and Stephen Stahl regarding the latest advances and developments affecting the clinical treatment of schizophrenia.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=907</link>
            <enclosure length="32914000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-10-treat/psychosis_pod-10-treat.mp3"/>
            <guid isPermaLink="false">http://cdn.neiglobal.com/content/rss/sages/pod-10-treat/psychosis_pod-10-treat.mp3</guid>
            <pubDate>Fri, 29 Oct 2008 17:00:00 -0700</pubDate>
            <itunes:subtitle>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "Contemporary Clinical Treatment of Schizophrenia". It includes the full discussion between Drs. Andrew Cutler and Stephen Stahl regarding the latest advances and developments affecting the clinical treatment of schizophrenia.</itunes:subtitle>
            <itunes:summary>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "Contemporary Clinical Treatment of Schizophrenia". It includes the full discussion between Drs. Andrew Cutler and Stephen Stahl regarding the latest advances and developments affecting the clinical treatment of schizophrenia.</itunes:summary>
            <itunes:duration>46:48</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:keywords>schizophrenia</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author></item>			
        <item>
            <title>From Clinical Trials to Clinical Practice: Recent Developments in Antipsychotic Therapy</title>
            <description>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "From Clinical Trials to Clinical Practice: Recent Developments in Antipsychotic Therapy". It includes the full discussion between Drs. Andrew Cutler and Stephen Stahl regarding the mechanistic and clinical profiles of recently approved antipsychotics as well as of those in late-stage and earlier clinical development.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=840</link>
            <enclosure length="22000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-10-trials/psychosis_podcast.mp3"/>
            <guid isPermaLink="false">http://cdn.neiglobal.com/content/rss/sages/pod-10-trials/psychosis_podcast.mp3</guid>
            <pubDate>Mon, 29 Mar 2010 12:00:00 -0700</pubDate>
            <itunes:subtitle>From Clinical Trials to Clinical Practice: Recent Developments in Antipsychotic Therapy</itunes:subtitle>
            <itunes:summary>This podcast is the archived version of NEI's Sages of Psychopharmacology Webinar titled "From Clinical Trials to Clinical Practice: Recent Developments in Antipsychotic Therapy". It includes the full discussion between Drs. Andrew Cutler and Stephen Stahl regarding the mechanistic and clinical profiles of recently approved antipsychotics as well as of those in late-stage and earlier clinical development.</itunes:summary>
            <itunes:duration>00:48:22</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Bringing Adult-Onset ADHD Into Focus. Episode 3: Adult ADHD--How Should it Be Treated?</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 3 focuses on treatment and management strategies for adults with ADHD.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=710</link>
            <enclosure length="13000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-adlt/pod-09adhd-adlt3.mp3"/>
            <guid isPermaLink="false">B8A4AA7B-C80C-4B3E-AEAF-8B6A0A51F661</guid>
            <pubDate>Thu, 29 Oct 2009 09:53:04 -0700</pubDate>
            <itunes:subtitle>Bringing Adult-Onset ADHD Into Focus. Episode 3: Adult ADHD--How Should it Be Treated?</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 3 focuses on treatment and management strategies for adults with ADHD.</itunes:summary>
            <itunes:duration>00:20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Bringing Adult-Onset ADHD Into Focus. Episode 2: Adult ADHD--How is it Diagnosed?</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 2 addresses diagnostic controversies and recommendations regarding late-onset and late diagnosis of ADHD.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=709</link>
            <enclosure length="9000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-adlt/pod-09adhd-adlt2.mp3"/>
            <guid isPermaLink="false">B1A90B68-72A2-488F-B338-8967A23EA7B8</guid>
            <pubDate>Thu, 29 Oct 2009 09:51:41 -0700</pubDate>
            <itunes:subtitle>Bringing Adult-Onset ADHD Into Focus. Episode 2: Adult ADHD--How is it Diagnosed?</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 2 addresses diagnostic controversies and recommendations regarding late-onset and late diagnosis of ADHD.</itunes:summary>
            <itunes:duration>00:20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Bringing Adult-Onset ADHD Into Focus. Episode 1: Adult ADHD--What Does it Look Like?</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 1 focuses on the presentation of ADHD in adults and how it typically differs from that in children.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=708</link>
            <enclosure length="11000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-adlt/pod-09adhd-adlt1.mp3"/>
            <guid isPermaLink="false">5C0953AB-4FCD-4840-A50C-17499FF2DA47</guid>
            <pubDate>Thu, 29 Oct 2009 09:50:11 -0700</pubDate>
            <itunes:subtitle>Bringing Adult-Onset ADHD Into Focus. Episode 1: Adult ADHD--What Does it Look Like?</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and David Goodman discuss the diagnosis and treatment of ADHD in adults. Episode 1 focuses on the presentation of ADHD in adults and how it typically differs from that in children.</itunes:summary>
            <itunes:duration>00:20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 3: The Previously Undiagnosed Adult with ADHD</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 3 addresses diagnostic and treatment issues for adults with ADHD who were never diagnosed as children.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=707</link>
            <enclosure length="12000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-ages/pod-09adhd-ages3.mp3"/>
            <guid isPermaLink="false">2C23EF97-707A-4760-BE3F-CB5BAEAFFE5E</guid>
            <pubDate>Wed, 28 Oct 2009 17:01:02 -0700</pubDate>
            <itunes:subtitle>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 3: The Previously Undiagnosed Adult with ADHD</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 3 addresses diagnostic and treatment issues for adults with ADHD who were never diagnosed as children.</itunes:summary>
            <itunes:duration>20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 2: The Evolution of ADHD</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 2 addresses evolving management strategies for patients with ADHD as they progress from childhood to adulthood.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=706</link>
            <enclosure length="12000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-ages/pod-09adhd-ages2.mp3"/>
            <guid isPermaLink="false">F640832B-6003-47A5-A1F7-AE01AECF6A5C</guid>
            <pubDate>Wed, 28 Oct 2009 16:59:02 -0700</pubDate>
            <itunes:subtitle>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 2: The Evolution of ADHD</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 2 addresses evolving management strategies for patients with ADHD as they progress from childhood to adulthood.</itunes:summary>
            <itunes:duration>20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 1: Pediatric ADHD</title>
            <description>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 1 focuses on the diagnosis and treatment of ADHD in children.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=705</link>
            <enclosure length="12000000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09adhd-ages/pod-09adhd-ages1.mp3"/>
            <guid isPermaLink="false">C7281CEB-42A9-42B4-8E42-EE3B8B965BDB</guid>
            <pubDate>Wed, 28 Oct 2009 16:56:15 -0700</pubDate>
            <itunes:subtitle>ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 1: Pediatric ADHD</itunes:subtitle>
            <itunes:summary>In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 1 focuses on the diagnosis and treatment of ADHD in children.</itunes:summary>
            <itunes:duration>20:00</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 3: Depression Treatment and Suicide Rates Following the Black Box Warnings</title>
            <description>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 3, Drs. Sid Zisook and Stephen Stahl discuss an overview of the evidence regarding suicide and depression treatment trends since the implementation of the antidepressant black box warning, and guidance on appropriate monitoring strategies for patients with depression, with emphasis on the adolescent population.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=636</link>
            <enclosure length="14889000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09-bbw/bbwpart3.mp3"/>
            <guid isPermaLink="false">0669F1AC-75D7-4B8C-96F1-7AA95BE2E92A</guid>
            <pubDate>Tue, 18 Aug 2009 14:50:17 -0700</pubDate>
            <itunes:subtitle>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 3: Depression Treatment and Suicide Rates Following the Black Box Warnings</itunes:subtitle>
            <itunes:summary>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 3, Drs. Sid Zisook and Stephen Stahl discuss an overview of the evidence regarding suicide and depression treatment trends since the implementation of the antidepressant black box warning, and guidance on appropriate monitoring strategies for patients with depression, with emphasis on the adolescent population.</itunes:summary>
            <itunes:duration>21:10</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 2: Activation, Agitation, and Mania: Symptoms or Antidepressant Side Effects?</title>
            <description>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 2, Drs. Sid Zisook and Stephen Stahl discuss potential side effects of antidepressants that may be related to increased risk for suicidality, and the evidence for increased risk with antidepressants in different age groups.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=635</link>
            <enclosure length="15080000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09-bbw/bbwpart2.mp3"/>
            <guid isPermaLink="false">BFD81498-30A8-454A-BE22-71849EB8DC22</guid>
            <pubDate>Tue, 18 Aug 2009 14:47:26 -0700</pubDate>
            <itunes:subtitle>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 2: Activation, Agitation, and Mania: Symptoms or Antidepressant Side Effects?</itunes:subtitle>
            <itunes:summary>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 2, Drs. Sid Zisook and Stephen Stahl discuss potential side effects of antidepressants that may be related to increased risk for suicidality, and the evidence for increased risk with antidepressants in different age groups.</itunes:summary>
            <itunes:duration>21:26</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 1: Neurobiology of Suicidality and Mechanisms of Antidepressant Medications</title>
            <description>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 1, Drs. Sid Zisook and Stephen Stahl discuss what is currently known about the neurobiology underlying suicidality and mechanisms of action of antidepressants that may be related to that neurobiology.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=634</link>
            <enclosure length="15144000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-09-bbw/bbwpart1.mp3"/>
            <guid isPermaLink="false">BD2B5625-6ACB-4FFE-A12E-8291FEE485F5</guid>
            <pubDate>Tue, 18 Aug 2009 14:44:05 -0700</pubDate>
            <itunes:subtitle>Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide, Part 1: Neurobiology of Suicidality and Mechanisms of Antidepressant Medications</itunes:subtitle>
            <itunes:summary>The podcast series titled "Black Box Warnings: Implications for Clinical Practice, Antidepressants, and Suicide" is divided into three parts. In Part 1, Drs. Sid Zisook and Stephen Stahl discuss what is currently known about the neurobiology underlying suicidality and mechanisms of action of antidepressants that may be related to that neurobiology.</itunes:summary>
            <itunes:duration>21:31</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Management of All Fibromyalgia Symptoms</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl examine the current treatment options available to treat the myriad symptoms of fibromyalgia. New treatment options are also reviewed in light of recent findings regarding chronic pain.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=536</link>
            <enclosure length="28390000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-fib/03_pod-08-fib3-mgmt.mp3"/>
            <guid isPermaLink="false">F597D0E1-10FB-414E-BB1D-9B2B960596F5</guid>
            <pubDate>Sun, 11 Jan 2009 20:15:53 -0800</pubDate>
            <itunes:subtitle>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Management of All Fibromyalgia Symptoms</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl examine the current treatment options available to treat the myriad symptoms of fibromyalgia. New treatment options are also reviewed in light of recent findings regarding chronic pain.</itunes:summary>
            <itunes:duration>30:16</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Pain, Depression and Sleep</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl discuss the myriad comorbidities associated with the syndrome of fibromyalgia. Patients often present complaining of fatigue as well as pain. Recent research suggests a link between pain, depression and sleep, which is discussed in this podcast.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=535</link>
            <enclosure length="16392000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-fib/02_pod-08-fib2-pain.mp3"/>
            <guid isPermaLink="false">33B88CEC-8E01-4AFD-BCAB-B147346914D9</guid>
            <pubDate>Sun, 28 Dec 2008 20:12:44 -0800</pubDate>
            <itunes:subtitle>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Pain, Depression and Sleep</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl discuss the myriad comorbidities associated with the syndrome of fibromyalgia. Patients often present complaining of fatigue as well as pain. Recent research suggests a link between pain, depression and sleep, which is discussed in this podcast.</itunes:summary>
            <itunes:duration>17:28</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Deconstructing the Syndrome of Fibromyalgia</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl discuss the syndrome of fibromyalgia at the neurobiological level. Current diagnostic guidelines are addressed, as well as providing recent information regarding the underlying causes of this painful syndrome. Gender differences in presentation are also discussed.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=534</link>
            <enclosure length="23788000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-fib/01_pod-08-fib1-deco.mp3"/>
            <guid isPermaLink="false">19C237C1-D421-425D-8BA6-2F03DCA2AAA0</guid>
            <pubDate>Sun, 14 Dec 2008 20:08:58 -0800</pubDate>
            <itunes:subtitle>Identifying and Treating All Aspects of Fibromyalgia: A New Look Into a Painful Syndrome - Deconstructing the Syndrome of Fibromyalgia</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl discuss the syndrome of fibromyalgia at the neurobiological level. Current diagnostic guidelines are addressed, as well as providing recent information regarding the underlying causes of this painful syndrome. Gender differences in presentation are also discussed.</itunes:summary>
            <itunes:duration>25:22</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Rationally Combining Mood Stabilizers for Optimum Outcomes</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl debate how to achieve the optimum outcome in mood disorders. They describe rational combinations of mood stabilizing drugs and highlight some dangerous combinations, including when and why to avoid them.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=533</link>
            <enclosure length="23293000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-bip/03_pod-08-bip3-combo.mp3"/>
            <guid isPermaLink="false">48EA4CE5-93CA-43D4-9DEF-10698ECCDE9C</guid>
            <pubDate>Sun, 11 Jan 2009 20:05:50 -0800</pubDate>
            <itunes:subtitle>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Rationally Combining Mood Stabilizers for Optimum Outcomes</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl debate how to achieve the optimum outcome in mood disorders. They describe rational combinations of mood stabilizing drugs and highlight some dangerous combinations, including when and why to avoid them.</itunes:summary>
            <itunes:duration>24:50</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Dosing Atypical Antipsychotics as Mood Stabilizers</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl describe the efficacy of atypical antipsychotics as mood stabilizers and discuss dosing practices for these agents from a disease-state-dependent perspective.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=532</link>
            <enclosure length="22400000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-bip/02_pod-08-bip2-dose.mp3"/>
            <guid isPermaLink="false">C19EC432-6500-4280-B16F-515B2B59DA1B</guid>
            <pubDate>Sun, 28 Dec 2008 20:02:39 -0800</pubDate>
            <itunes:subtitle>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Dosing Atypical Antipsychotics as Mood Stabilizers</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl describe the efficacy of atypical antipsychotics as mood stabilizers and discuss dosing practices for these agents from a disease-state-dependent perspective.</itunes:summary>
            <itunes:duration>23:53</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Class of Mood Stabilizers</title>
            <description>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl differentiate between both pharmacological and clinical properties of different classes of mood stabilizers, and discuss examples of when one might choose one class of mood stabilizer over another.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=531</link>
            <enclosure length="22400000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/pod-08-bip/01_pod-08-bip1-class.mp3"/>
            <guid isPermaLink="false">02DAD104-F918-46E7-AA9C-C3B574BCB1CC</guid>
            <pubDate>Sun, 14 Dec 2008 19:58:03 -0800</pubDate>
            <itunes:subtitle>Differentiating, Dosing, and Combining Mood Stabilizing Drugs - Class of Mood Stabilizers</itunes:subtitle>
            <itunes:summary>In this podcast, Drs. Andrew Cutler and Stephen M. Stahl differentiate between both pharmacological and clinical properties of different classes of mood stabilizers, and discuss examples of when one might choose one class of mood stabilizer over another.</itunes:summary>
            <itunes:duration>23:53</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author><itunes:keywords>CME,Neuroscience,Education,Institute,NEI,psychopharmacology,psychiatry,Stahl,neuropsychiatric,diseases,Sages,of,Psychopharmacology</itunes:keywords></item>
        <item>
            <title>The Reality of ADHD in Adults: Diagnostic Issues</title>
            <description>"Diagnostic Issues" discusses the evolution of ADHD from childhood to adulthood, and provides information on how the disorder can be identified in different age groups, using adequate rating scales.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=470</link>
            <enclosure length="9511000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/realityadhdadults/08podcast1-diag.mp3"/>
            <guid isPermaLink="false">C68CDC02-0330-4221-A236-ED1755E02716</guid>
            <pubDate>Thu, 18 Sep 2008 18:21:31 -0700</pubDate>
            <itunes:subtitle>"Diagnostic Issues" discusses the evolution of ADHD from childhood to adulthood, and provides information on how the disorder can be identified in different age groups, using adequate rating scales.</itunes:subtitle>
            <itunes:summary>"Diagnostic Issues" discusses the evolution of ADHD from childhood to adulthood, and provides information on how the disorder can be identified in different age groups, using adequate rating scales.</itunes:summary>
            <itunes:duration>20:16</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:keywords>ADHD, childhood, adulthood, child, treatment</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author></item>
        <item>
            <title>The Reality of ADHD in Adults: Treatment Issues</title>
            <description>"Treatment Issues" discusses the different medications used to treat ADHD and elaborates on the differences and similarities between treating children and adults with the disorder. Different drug formulations are also mentioned in this podcast.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=471</link>
            <enclosure length="12268000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/realityadhdadults/08podcast2-treat.mp3"/>
            <guid isPermaLink="false">A0DAFE35-A180-41C6-9697-F6460D3B8FC3</guid>
            <pubDate>Thu, 18 Sep 2008 18:21:32 -0700</pubDate>
            <itunes:subtitle>"Treatment Issues" discusses the different medications used to treat ADHD and elaborates on the differences and similarities between treating children and adults with the disorder. Different drug formulations are also mentioned in this podcast.</itunes:subtitle>
            <itunes:summary>"Treatment Issues" discusses the different medications used to treat ADHD and elaborates on the differences and similarities between treating children and adults with the disorder. Different drug formulations are also mentioned in this podcast.</itunes:summary>
            <itunes:duration>26:09</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:keywords>ADHD, childhood, adulthood, child, drug formulations, treatment</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author></item>
        <item>
            <title>The Reality of ADHD in Adults: Comorbidities in ADHD</title>
            <description>"Comorbidities in ADHD" elaborates on the different comorbidities present in children and adults with ADHD, and discusses how to best treat them.</description>
            <link>http://www.neiglobal.com/Default.aspx?tabid=472</link>
            <enclosure length="11183000" type="audio/mpeg" url="http://cdn.neiglobal.com/content/rss/sages/realityadhdadults/08podcast3-comorb.mp3"/>
            <guid isPermaLink="false">8E4F6179-8612-4785-832B-C7D27FFA219A</guid>
            <pubDate>Thu, 18 Sep 2008 18:21:33 -0700</pubDate>
            <itunes:subtitle>"Comorbidities in ADHD" elaborates on the different comorbidities present in children and adults with ADHD, and discusses how to best treat them.</itunes:subtitle>
            <itunes:summary>"Comorbidities in ADHD" elaborates on the different comorbidities present in children and adults with ADHD, and discusses how to best treat them.</itunes:summary>
            <itunes:duration>23:50</itunes:duration>
            <itunes:author>Neuroscience Education Institute</itunes:author>
            <itunes:keywords>ADHD, childhood, adulthood, child, treatment</itunes:keywords>
            <itunes:explicit>no</itunes:explicit>
            <itunes:block>no</itunes:block>
        <author>webmaster@neiglobal.com (Neuroscience Education Institute)</author></item>
    </channel>
</rss>